text:
CBD Guides
CBD Oil for Sleep & Insomnia
Best CBD Oil for Anxiety: How CBD Helps with Stress & Depression
Nina Julia
We all experience anxiety at one point or another.
Roughly 40 million Americans are diagnosed with clinical anxiety disorders every year, and countless others experience some form of anxiety on a daily or weekly basis. This anxiety can take a toll on our lives — affecting our relationships, performance at work or school, and our overall health and wellbeing.
One of the most popular alternative support options among anxiety sufferers is cannabidiol (CBD) — a non-psychoactive cannabinoid found in the hemp plant. This compound works through two main systems to promote a feeling of calmness and relaxation.
In this article, we'll explain how CBD is suggested to support anxiety, what the research says, and offer some of the best hemp oil options for anxiety.
1 5 Best CBD Oils for Anxiety (Top Quality Brands)
1.1 1. Royal CBD
1.1.1 Technical Details:
1.1.2 What We Like About Royal CBD Oil:
1.1.3 Pros
1.1.4 Cons
1.2 See Lowest Price
1.3 2. CBDPure (Runner Up)
1.3.2 What We Like About CBDPure CBD Oil:
1.4 3. HempBombs
1.4.2 What We Like About HempBombs CBD Oil:
1.5 4. CBDistillery
1.5.2 What We Like About CBDistillery CBD Oil:
1.6 5. NuLeaf Naturals
2 What is CBD Oil?
3 What Causes Anxiety?
4 Why Are Pharmaceutical Anxiety Medications Dangerous To Our Health?
5 CBD Oil For Anxiety
5.1 1. Serotonin Receptors & Brain Activity
5.2 2. Anandamide Production — The Bliss Molecule
5.3 3. Hippocampal Neurogenesis — Homeostasis & Anxiety
5.4 4. GABA Receptors — The Brake Pedals for the Brain
6 The Best CBD Oil For Anxiety: What to Look For
6.1 1. Hemp Source — Opt For Domestic
6.2 2. Extraction Method — Look For CO2 Extraction
6.3 3. Full-Spectrum Hemp vs. CBD Isolate
6.4 4. Additional Ingredients
6.5 5. Laboratory Testing Results
7 CBD Oil For Anxiety: A Brief Summary
7.0.1 References:
Best Overall CBD Oil
Royal CBD – Full Spectrum
Rated #1 for overall anxiety and depression relief
Highest quality hemp oil on our list
100% organic, free of pesticides, and artificial ingredients
Established brand with 24/7 customer support
30-day 100% money-back guarantee
CBDPure Oil
Good customer support
5 Best CBD Oils for Anxiety (Top Quality Brands)
Best Overall Pick: Royal CBD
Runner Up: CBD Pure
Good Customer Support: Hempbombs
Veteran Brand: CBDistillery
Most Socially Responsible: NuLeaf Naturals
The CBD market hasn't yet matured — which means there are a ton of brands offering really poor quality products. They're managing to remain in business on hype alone. As the market matures, these companies won't last — leaving only the best brands in the wake.
At this early stage in the market, it's important that customers understand how to spot a good CBD manufacturer, and which companies to avoid.
To make things easier for you, I've compiled a shortlist of the best CBD oils I've come across for anxiety. Let's cover each one in more detail before we go on to discuss exactly how CBD is reported to help with anxiety.
1. Royal CBD
Total CBD Content 250 – 1000 mg
Available Flavors Berry, vanilla, mint, natural
Potency 8.3 – 33.3 mg/mL
What We Like About Royal CBD Oil:
Royal CBD is a California-based CBD brand with a growing collection of reviews from both regular users and industry experts.
Unlike many of its competitors, Royal CBD doesn't rely on far-fetched claims in their marketing. The company also doesn't specialize in gimmicky product types like we've seen from numerous other brands recently. The Royal CBD assortment is all about the classics. They keep it simple, focusing on full-spectrum CBD oil, THC-free CBD gummies, capsules, and CBD-infused topicals.
Royal CBD uses organically-grown hemp from the finest farms in California and Colorado. The company makes this CBD oil by first making a full-spectrum hemp extract using supercritical CO2. The extract is then dissolved in high-grade MCT oil and some flavorings to make the oil more enjoyable to use.
This CBD oil comes in 250 mg, 500 mg, and 1000 mg – with the option of berry, mint, or other natural flavors.
I personally use Royal CBD's 1000 mg full-spectrum CBD oil for my general anxiety disorder (GAD) & social anxiety. I should note that I tried 27 other brands before finding the one I liked!
With a 90-day, no questions money back guarantee – the only thing you have to lose your anxiety.
Extremely potent (33mg of CBD per serving for 1000 mg bottle)
Contains the full spectrum of phytocannabinoids
Made from 100% natural ingredients
Third-party tested for potency & purity
No CBD vape oils or creams availlable from the company
Only comes in a full-spectrum extract
See Lowest Price
2. CBDPure (Runner Up)
Total CBD Content 100 – 600 mg
Available Flavors None
Potency 20 mg/mL
What We Like About CBDPure CBD Oil:
Similar to the other brands in our ranking, CBDPure sells full-spectrum CBD oil that has been sourced from domestically grown hemp and extracted with supercritical CO2.
If you're looking for the highest potency, though, you might end up a little bit disappointed, as the maximum strength offered by their products is 600 mg of CBD per bottle, which is equal to 20 mg of CBD per mL. Our first choice, Royal CBD, has 30% higher potency than the strongest option available for this brand.
The good news is that these are full-spectrum extracts, so you need less CBD to find relief from anxiety than you would with CBD isolate. Each batch of CBDPure products is tested in a certified laboratory for the entire cannabinoid profile, terpenes, and flavonoids, as well as for potential contaminants.
If you're not satisfied with this CBD oil for your anxiety, CBDPure has a 100% Satisfaction Guaranteed program, which allows you to get a full refund if you send the order back within 90 days after the purchase.
Extracted with supercritical CO2
Extensively tested in 3rd-party laboratories
You can get a full refund within 90 days if you're not satisfied with the product
Only available as oil drops or softgel capsules
Low potency (20 mg of CBD/mL maximum)
No flavored options
They don't ship to Arkansas, Louisiana, Indiana, and Kansas
3. HempBombs
Available Flavors Peppermint & watermelon
Potency 10 – 133.3 mg/mL
What We Like About HempBombs CBD Oil:
HempBombs is an American company specializing in the production of 99% pure CBD isolates. These products are available as standard tinctures, vape oils, capsules, or gummies.
Hemp Bombs CBD oil comes in five different potency options ranging from 300 mg to as much as 4000 mg of CBD per bottle. The CBD has been sourced from certified organic hemp plants from Europe and extracted with supercritical CO2 for the highest purity level.
This CBD oil option is made from CBD isolate — which means there's nothing but pure CBD inside this oil. No THC or other cannabinoids, terpenes, or any other phytochemicals from the hemp plant. This offers a big advantage in that there's guaranteed to be no THC in the bottle.
Isolate-based CBD oils are very versatile — you use them on their own, make DIY CBD infusions (e.g. creams and balms), add it to E-liquid for an extra punch, or use it in cooking delicious food. They're also preferred for people who are using CBD alongside other supplements because there's fewer compounds that can potentially interact with the other health supplements.
Keep in mind that CBD isolate is purged from any cannabinoids other than CBD — so if you're looking to take advantage of the entourage effect, you're better off going for a full-spectrum CBD oil such as Royal CBD.
Sourced from 100% certified organic hemp from European farmers
Extracted with CO2
Lab-tested for purity and potency
Available in 5 potency options
Less expensive than full-spectrum extracts
Not certified organic
No entourage effect from other cannabinoids
The ultra-high potency options are overkill for most users
4. CBDistillery
Available Flavors Unflavored
Potency 8.3 – 166 mg/mL
What We Like About CBDistillery CBD Oil:
CBDistillery is an industry veteran, but make no mistake, the brand hasn't rested on its laurels. On the contrary, CBDistillery continues to set high standards for its competitors, both in terms of the quality of ingredients and the potency of its products.
CBDistillery's CBD oil is available in five different potencies, starting from 250 mg up to 5000 mg of full-spectrum CBD. The 2500 mg and 5000 mg options come in 30 mL bottles, which breaks down to 83–166 mg per serving — that's enough CBD to keep you supplied for weeks or months.
What I love about CBDistillery's assortment is that its products are sold at very reasonable prices. The 250 mg CBD oil costs around $20, so you don't have to break the bank to get yourself a high-quality health supplement.
Users can choose between full-spectrum CBD oil and THC-free (broad-spectrum) oil, which is a nice move towards those who want to keep any traces of THC away from their system without losing the benefits offered by the entourage effect.
Sourced from non-GMO, pesticide-free hemp
Available as full-spectrum CBD or pure CBD oil (THC-free)
Lab-tested for the cannabinoid content and purity levels
Available in 5 different potency options
Good price/quality ratio
5. NuLeaf Naturals
What We Like About NuLeaf Naturals CBD Oil:
NuLeaf Naturals is another veteran brand that's been selling CBD oil for over 5 years now. While they don't have the broadest range of CBD products — only oil drops for humans and pets — this company definitely knows how to make an all-natural CBD oil.
All Nuleaf Naturals oils are sourced from domestic hemp and extracted with CO2. NuLeaf Naturals CBD oil has a beautiful amber-gold color, which is a good indicator of its quality. The oil is then filtered to remove any remaining plant matter.
NuLeaf sells its products in five different volumes — all in the same potency of 48 mg.mL CBD:
5 mL — 240 mg of CBD total
15 mL — 725 mg of CBD total
30 mL — 1450 mg of CBD total
100 mL — 4850 mg of CBD total
Made from 100% organic, Colorado-grown hemp
Extracted with a combination of subcritical and supercritical CO2
Lab-tested for potency and over 200 common contaminants
Full-spectrum extracts
Available for both humans and pets
Narrow product range
More expensive than much of the competition
CBD, short for cannabidiol, is one of the active ingredients in the cannabis plant (Cannabis sativa). This includes both industrial hemp plants, and marijuana.
CBD is the modulator to the endocannabinoid system — a complex neurochemical network responsible for controlling various vital functions in the human body and brain. The endocannabinoid system regulates processes such as:
Cognitive performance
Reproduction and fertility
Mood and emotion
Hunger and satiety
CBD helps the endocannabinoid system maintain chemical balance within the body — also known as "homeostasis" or "equilibrium." If homeostasis isn't maintained, we become sick. Depending on which aspect of homeostasis is out of balance — the effects on the body will be very different. If our nervous system is affected, it can lead to symptoms of anxiety, stress, and emotional instability.
CBD has other effects on the body as well — the most relevant in the context of this article are its effects on a neurotransmitter called GABA — which is responsible for slowing us down when we become overstimulated. We'll get into how this works in more detail later.
There are many different ways to use CBD — it's added to capsules, infused in topical salves and creams, mixed into gummy candies, and added to vape oils. But by far the most popular form of the supplement is in the form of an oil. CBD oils are made by mixing the fat-soluble hemp extracts rich in CBD and other cannabinoids with an oil base — in most cases MCT oil or hemp seed oil.
Using CBD in the form of an oil makes it easier to measure doses since you simply have to count the number of drops or measure the oil with the built-in dropper. Compare this to pure hemp extracts which require scales and a lot of experience to accurately measure the right dose.
Additionally, the oil content of CBD oils significantly improve the absorption rate in the digestive tract. This helps make the CBD more efficient — allowing you to use less CBD for the same level of benefits.
Anxiety is defined as "an emotion characterized by feelings of tension, worried thoughts and physical changes like increased blood pressure." It's a natural process developed over the course of human evolution to protect us from environmental threats like changes in our environment, exposure to predators or other dangers. Feeling anxious helps us identify and avoid dangers that pose a threat to our health and wellbeing.
Anxiety can also become pathological — leading us to feel excessive stress and worry in situations that are not life-threatening. Modern stresses like work deadlines, relationship problems, or social expectations can all cause us to feel anxious. If this happens too often or in excessive amounts, it can cause us more harm than good.
There are many forms and levels of intensity of anxiety symptoms — including generalized anxiety disorder, panic disorder, post-traumatic stress disorder, social anxiety, insomnia, and many different phobias.
It's wise to speak with your doctor if you experience severe anxiety attacks, or if your anxiety begins affecting your ability to live your life. There are many underlying causes for anxiety, so it's best if a medical professional can explore some of these options to help you find the best form of treatment.
Why Are Pharmaceutical Anxiety Medications Dangerous To Our Health?
The most common form of drug treatment for anxiety is a class known as benzodiazepines. These medications bind to the GABA receptors in the brain to force electrical activity to slow down — thus alleviating the most common signs of anxiety. This works in a similar way to CBD, but significantly stronger and more specific.
The main problem with conventional anti-anxiety medications is that they can become highly addictive — often leading to a worsening of symptoms over time as tolerance to the medications begins to form.
You take benzodiazepines to fight anxiety and for a time it works. However, the body quickly forms a tolerance to the medication to resist its effects by removing some of the GABA receptors. Once these receptors are gone, we need more of the medication to produce the same effect. This process continues until we've reached the maximum dose for the drug. If the drug starts to wear off, we no longer have enough GABA receptor activity to keep our nervous system from going into hyperdrive — forcing us into a state of extreme anxiety.
The body will eventually reach a point where we require the drug just to not have an anxiety attack.
Benzodiazepines aren't the only option, but they're the most common. Other classes of medications used for treating anxiety have similar effects long-term.
Some examples of anti-anxiety medications include:
Side-effects to these medications are common and can range in severity. Most of the drug classes on the list will cause tolerance in the body as described above.
Here are some of the most severe side effects of prescription anti-anxiety medications:
Galactorrhoea
Cardiac disease
With all these negatives, it's no wonder why CBD has become such a popular alternative treatment option for anxiety and related conditions.
At the very beginning of the article, we mentioned that the endocannabinoid system regulates our response to fear among many other functions.
Unlike conventional anti-anxiety treatments, CBD oil doesn't just mitigate the symptoms of anxiety — it gets down to the root of the problem by regulating endocrine disruptions as well as the amount of anandamide in our brains — a compound aptly named the "bliss molecule."
CBD has been shown to help with anxiety in a few different ways. While the majority of research describing how CBD works for this disorder is either preclinical or based on animal studies, there are hundreds (if not thousands) of testimonies from people who have found relief in CBD oil after failing with the conventional treatment. There are also a handful of randomized, double-blind, clinical trials conducted on the interaction as well. These are considered to be the highest form of clinical research available.
Let's cover the mechanisms of action CBD oil uses to support anxiety levels and what the research says about this incredibly useful molecule.
1. Serotonin Receptors & Brain Activity
CBD has been shown to stimulate the 5HT1 serotonin receptors. In simple terms, this cannabinoid increases serotonin activity in the brain — which affects the transmission of electrical activity as well as mood, concentration, and sleep.
Studies have shown a direct link between the activity of serotonin as the 5HT1 and 5HT2 serotonin receptors in the central nervous system and anxiety disorders.
2. Anandamide Production — The Bliss Molecule
The next anti-anxiety effect of CBD is linked to its ability to increase the amount of the body's natural endocannabinoids — anandamide and 2-AG. This effect is particularly prominent for anandamide in particular.
Anandamide has almost the same chemical structure as THC, the cannabinoid responsible for triggering euphoric and psychoactive effects in cannabis users.
Anandamide doesn't cause psychoactive effects like THC, but it is closely correlated with feelings of bliss, joy, and euphoria. In contrast, lower anandamide levels are thought to result in a low mood or "overreaction" to stress and anxiety triggers.
CBD has been shown to enhance the activity of anandamide by preventing its breakdown and metabolism — ultimately leading to elevated levels of the bliss molecule in the brain.
3. Hippocampal Neurogenesis — Homeostasis & Anxiety
The hippocampus is a critical brain region tasked with controlling homeostasis in both the brain and body.
Brains scans of patients struggling with anxiety and depression often exhibit changes in the hippocampus, and successful anxiety treatment is associated with the production of new neurons (neurogenesis) in this area. Some research has shown
It appears that CBD may stimulate the hippocampus to regenerate neurons, which could be groundbreaking for anxiety patients (5).
Current evidence suggests that severely damaged neuronal plasticity may influence suicidal behavior, so by regenerating neurons in the hippocampus is thought to reduce the chances of depressive behavior such as this.
4. GABA Receptors — The Brake Pedals for the Brain
Earlier we spoke about the interaction CBD has with our GABA receptors. Let's dig into this a little more and discuss exactly how this works and how it relates to anxiety.
GABA essentially acts as the brake pedal for the nervous system. It's used to keep our speed in check when we become agitated. If GABA isn't doing its job effectively we can quickly begin to speed out of control — resulting in symptoms commonly referred to as anxiety.
CBD binds to the GABA receptors in the nerve cells and makes them more sensitive to GABA. This would be like changing the brake pads on your car so you don't have to hit the pedal as hard to begin slowing down.
Research has shown that insufficient GABA activity is closely involved in the development of anxiety disorders. CBD has been shown to interact with the GABAa receptors in the neurons, offering a clear mechanism for its anti-anxiety benefits. Other cannabinoids in the cannabis plant have also been shown to support this process through GABA and other chemical pathways in the brain.
The Best CBD Oil For Anxiety: What to Look For
The hemp industry has proven to be a lucrative market for many companies, but as with so many emerging businesses, it's a tantalizing sector for sketchy companies trying to cash in on unaware customers.
You want to steer clear of inferior CBD supplements as much as possible. Such products are often made from low-quality hemp, extracted with toxic solvents, and promise a lot more than CBD oil is actually capable of.
When searching for the best CBD products for anxiety online or in local stores near you, keep an eye out for the following details:
1. Hemp Source — Opt For Domestic
Hemp is an effective bioaccumulator, meaning it absorbs everything from the soil it grows in. When grown in polluted soil, the plant may accumulate heavy metals and other harmful toxins, resulting in a poor end product. Hemp grown in places like China or India is especially high in these toxic elements because of high soil contamination in the region.
If you want a high-quality CBD oil to help you deal with anxiety, look for products that have been sourced from domestically grown hemp. US farmers are subject to strict quality control standards and the growing competition prevents them from cutting corners in their cultivation practices.
Plus, many US growers use organic growing methods even if their CBD oil is not certified organic, mainly due to the high cost of these certifications. Always ask your potential vendor how they source their plants to ensure you're not throwing your money down the drain.
2. Extraction Method — Look For CO2 Extraction
The majority of high-quality CBD oils are extracted with supercritical carbon dioxide. This method produces a pure and highly potent product, leaving you with pure extracts free of any toxic solvent residue.
CBD tinctures, which are a bit different than CBD oil, are extracted with high-proof alcohol. Some less common extraction methods call for using olive oil, but when a company isn't open about how it obtain its CBD extracts, a few red flags should be raised because that means they probably applied some toxic solvents in the process. And what's worse, there's a risk these solvents weren't completely removed after extraction.
3. Full-Spectrum Hemp vs. CBD Isolate
What do you want to achieve with your CBD oil aside from anxiety relief?
Are you aiming at maximizing your CBD dose per serving?
Or is the whole-plant synergy more important than the potency of cannabidiol?
If you want a versatile product and high doses of CBD — isolate-based CBD oil will be your best bet. On the other hand, full-spectrum extracts offer one perk that isolates users cannot achieve with their products — the entourage effect.
The entourage effect refers to the synergistic effect achieved by all active compounds in cannabis plants. Researchers suggest each of these compounds work in unison to amplify the benefits of one another, resulting in a greater therapeutic potential.
The cannabis community appears to support this concept; the Internet is full of testimonies from people who switched from isolates to full-spectrum CBD oil for anxiety because they needed lower doses to get relief.
4. Additional Ingredients
High-quality CBD oil contains two main ingredients — the CBD extract and carrier oil in which the CBD is dissolved.
Additionally, CBD oil can have some natural flavorings added to mask the hemp aftertaste. Some products are infused with supplementary herbs and organic compounds to amplify the stress relieving properties of cannabidiol — such as chamomile or melatonin.
In general, a complex formula involving hemp extract and other herbs and nutrients formulated for a specific application is going to be better overall.
5. Laboratory Testing Results
3rd-party lab testing is the ultimate way to verify the credibility of your CBD vendor.
Not only do such tests check for the potency of CBD in the final product, they also list the entire cannabinoid profile and can detect any impurities that could compromise its quality.
If the brand actually uses premium ingredients in its CBD oil (as they claim), they should be open about their lab testing reports and list the results publically on the company website. If these tests aren't available, we suggest you move on to look elsewhere for a company that does this.
CBD Oil For Anxiety: A Brief Summary
As scientists conduct more research on the health benefits of CBD, we're beginning to unlock new applications of this incredible plant-extract. One of the hottest areas in research at the moment is for the use of CBD with anxiety.
CBD oil works by interacting with the endocannabinoid to support homeostasis (balance), modulate GABA activity, and support serotonin and anandamide levels — all of which play a key role in the process of stress and anxiety.
The greatest challenge lies in finding the best CBD oil for anxiety out of the sea of fly-by-night CBD brands. As long as you know what characteristics make for a great CBD brand, and what the red flags are for scam or poor-quality products — you should be able to find a product that suits your individual needs.
If you're not sure where to start, I highly recommend you go with Royal CBD as your CBD oil of choice. The 1000 mg option offers the best value for money, and high-grade full-spectrum extract has served me well with my anxiety in the past.
Have you tried using CBD for anxiety? How did it work for you? Let us know in the comments!
Beesdo, K., Knappe, S., & Pine, D. S. (2009). Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V. The Psychiatric clinics of North America, 32(3), 483–524.
Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics, 12(4), 825–836.
Russo, E.B., Burnett, A., Hall, B., and Parker, K.K. (2005). Agonistic Properties of Cannabidiol at 5-HT1a Receptors. Neurochemical Research, 30(8), 1037-1043.
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., … Koethe, D. (2012). Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational psychiatry, 2(3), e94.
Beale, C., Broyd, S. J., Chye, Y., Suo, C., Schira, M., Galettis, P., … Solowij, N. (2018). Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users. Cannabis and cannabinoid research, 3(1), 94–107.
Wenzel, A., Haugen, E. N., Jackson, L. C., & Brendle, J. R. (2005). Anxiety symptoms and disorders at eight weeks postpartum. Journal of anxiety disorders, 19(3), 295-311.
Bakas, T., Van Nieuwenhuijzen, P. S., Devenish, S. O., McGregor, I. S., Arnold, J. C., & Chebib, M. (2017). The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors. Pharmacological research, 119, 358-370.
A World Health Organizadon Demonstration Project. (1994). A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. Journal of palliative care, 10(1), 14-18.
Charney, D. S., Woods, S. W., Goodman, W. K., & Heninger, G. R. (1987). Serotonin function in anxiety. Psychopharmacology, 92(1), 14-24.
Bannerman, D. M., Rawlins, J. N. P., McHugh, S. B., Deacon, R. M. J., Yee, B. K., Bast, T., … & Feldon, J. (2004). Regional dissociations within the hippocampus—memory and anxiety. Neuroscience & Biobehavioral Reviews, 28(3), 273-283.
Nina created HMHB.org following the birth of her second child. She was a science and math teacher for 6 years prior to becoming a parent — teaching in schools in White Plains, New York and later in Paterson, New Jersey.
3 thoughts on "Best CBD Oil for Anxiety: How CBD Helps with Stress & Depression"
Jason Alden
Most of the people who take CBD oil to help with their anxiety decide to take the oil by ingesting it orally. CBD oil comes in many edible forms, including foods, beverages, and medicines.
Ramon Pons
Get a little bit light headed when using the cbd with thc,trying the cbd oil now without thc,it works but the one with the seems to have a better response to the isolate type,maybe I should try cbd oil with thc with less potancy
Sebastian Rahaus
Thanks, Nina for sharing Very useful information but at what age do I need to start feeding them.
We are a team of experts committed to promoting reproductive and pregnancy wellness through education, support, and awareness. Regardless of the question, we deliver instant answers and provide access to pertinent resources.
Healthy Moms Healthy Babies
We at HMHB strive to be a helping hand to all parents. Our goal is to provide detailed and accurate pregnancy and parenting information to anyone who needs it.
CBD Buying Guides
Best CBD Oil for Anxiety
Best CBD Oil for Arthritis
Follow HMHB
© 2020 Healthy Moms Healthy Babies. All rights reserved
HMHB.org is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com. Additionally, HMHB.org participates in various other affiliate programs, and we sometimes get a commission through purchases made through our links.


Roughly one of every three women will suffer from abnormal uterine bleeding at some point in their lives, writes advocate and award-winning journalist Holly Bridges in The UnHysterectomy: Solving your Painful, Heavy Bleeding Without Major Surgery. She's one of them, having suffered with uterine fibroids for almost two years.
This societal bias against menstruation leaves women uncomfortable discussing abnormal bleeding even with another woman. So imagine telling a man.
The commonality in these two experiences-from the first job to the lost job-is women's shame and embarrassment. The women behind the fibroid movement hope to foster women's confidence in speaking up about abnormal bleeding conditions, whether with other women, or with men. As Mazal Kimhi explains below, being open about her own experience, even with her son, can only help other women.
Next time, we'll look at the huge impact living with fibroids has on women's lives.
To see all of the Fibroid Movement videos click here.
Women with Fibroids Movement: Part Six—"Sheros" Wanted!


text:
The Countdown Library
'Countdown with Keith Olbermann' for Tuesday, December 15th, 2009
Guests: Howard Fineman, Howard Dean, Sen. Ron Wyden, Chris Kofinis, Chris Hayes, Gerald
(BEGIN VIDEOTAPE)
LAWRENCE O'DONNELL, GUEST HOST (voice-over): Which of these stories will you be talking about tomorrow?
The high stakes over health care reform: President Obama tells Democrats in the Senate, it's now or never.
BARACK OBAMA, PRESIDENT OF THE UNITED STATES: This reform has to pass on our watch.
O'DONNELL: But as the president defends what's left in the bill, Governor Howard Dean says it's time to kill it and start over.
And Joe Lieberman, the senator who's helped defend the insurance cartel, still isn't quite ready to support the watered-down bill.
SEN. JOE LIEBERMAN (I), CONNECTICUT: I'm getting toward that position where I can say what I've wanted to say all along, that I'm ready to vote for health care reform.
O'DONNELL: Tonight, our guests: Governor Dean on why it's time for a dramatic shift in tactics to achieve real reform; Senator Ron Wyden on the state of negotiations in the Senate; and Howard Fineman on the political stakes for Democrats and Joe Lieberman's vendetta against his former party.
The tea party crowd brings its road show to health care. They tried to stage a die-in to protest future rationing of health care, oblivious to the fact that people are already dying because of rationing today by insurance companies.
Is it the end of Gitmo? A deal is struck for the feds to buy a prison in Illinois to house the detainees. Cue: the fear from the GOP.
REP. JOHN BOEHNER (R-OH), MINORITY LEADER: They're going to try to paint this as a jobs plan, while making Americans less safe.
O'DONNELL: And Tiger Woods was already in enough trouble, but now, there are questions if he used drugs to give himself an unfair advantage on the golf course.
All that and more - now on Countdown.
(END VIDEOTAPE)
O'DONNELL: Good evening from Los Angeles. I'm Lawrence O'Donnell, in for Keith Olbermann.
The first campaign for president to suggest that people between the ages of 55 and 64 be allowed to buy in to Medicare was Gore-Lieberman in 2000. Four years later, that idea was picked up by Governor Howard Dean. Chairman Max Baucus included it in a preliminary outline of his finance committee bill.
But in our fifth story on the Countdown: Now that Senator Lieberman is blocking health care reform, even opposing the compromise that would have done away with the public option and replaced it with the Medicare buy-in he once supported, Dr. Dean has responded that the Democrats are left with a bill that is now worthless. Quoting him, "The best thing to do with it now is kill the bill."
In a moment, our interview with Governor Howard Dean.
But we begin tonight with the latest details: Governor Dean throwing down the gauntlet, if not throwing in the towel in the face of Senator Lieberman's continuing threat to keep the health care reform bill from an up-or-down vote in the Senate. The former Vermont governor told Vermont Public Radio tonight that what's left of the health care reform bill is not worth supporting.
Meanwhile, Senator Lieberman fired new shots today. First, he blamed liberals like Congressman Anthony Weiner for being too enthusiastic about expanding Medicare, telling "The New York Times," quote, "Congressman Weiner made a comment that Medicare buy-in is better than a public option. It's the beginning of a road to single-payer."
Tomorrow night, Congressman Weiner will join us to respond to Senator Lieberman.
Senator Lieberman also claimed today that with his health care position, he is not betraying any Democrats who re-elected him in 2000, telling reporters, quote, "I didn't run for re-election, and no one here did asking the voters of my state to vote for me because I would always do what a majority of members of the caucus did. But that I, like each of them, had to do what I thought was right."
But this is what Senator Lieberman promised voters in 2006, telling them in a debate, "What I'm saying to the people of Connecticut, I can do more for you and your families to get something done to make health care affordable to get universal health insurance."
Senator Ben Nelson said today that he is still looking for a stronger abortion restriction in the bill among other things. Moderate Republican Olympia Snowe said she is withholding her support and criticized the idea of trying to pass the bill before Christmas.
Lieberman, Nelson and other members of the Democratic Caucus met with President Obama for more than an hour at the White House this afternoon.
The president said he told the senators they cannot let their differences over portions of the measure kill the overall attempt to reform the health care system.
OBAMA: If we don't get this done, your premiums are guaranteed to go up. If this does not get done, more employers are going to drop coverage because they can't afford it. If this does not get done, it is guaranteed that Medicare and Medicaid will blow a hole through our budget.
Those things are guaranteed. That's the status quo. That is the trajectory that we are currently on.
I don't intend to have that happen. And I believe that the Senate doesn't intend to have that happen.
I am absolutely confident that if the American people know what's in this bill, and if the Senate knows what's in this bill, that this is going to pass, because it's right for America.
O'DONNELL: As promised, we are joined now by Governor Howard Dean, former chairman of the Democratic National Committee and a 2004 candidate for the Democratic presidential nomination.
Thank you for your time, Governor.
HOWARD DEAN, FMR. DNC CHAIRMAN: Thanks for having me on.
O'DONNELL: Governor Dean, you have been on this cause of health care reform for decades. There has been no more energetic cheerleader for this legislative crusade this time around than you. You have reached the point now where the Senate bill which is well on its way to becoming the Lieberman bill is something you can no longer support and you want to kill it. Tell us why.
DEAN: Well, I don't - I'm not going to give up on health care reform. I'm still hopeful that something will happen in the House, but it's not very likely because the conference committee vetoed by Joe and the other pro-insurance company Democrats when it comes back as well. So, real reform in the House is a lot less likely given what's happened in the Senate.
This is not real reform. It's not health care reform. There are no choices.
The decision has been made without really thinking about it. It's been made because people are exhausted and they want to pass a bill so desperately they're not thinking about what they're doing here. It's been made to commit the United States to health care reform through the private sector.
Now, I don't think that's a decision that should be made lightly. In the previous bills, the Medicare buy-in, the public option, had the choice of - mixtures of giving Americans the opportunity to make their own choices. Those choices have been taken away by the pro-insurance folks in the Senate. I think that's a mistake.
Are there some good things in this bill? Yes. This is basically the Mitt Romney bill in Massachusetts, except it doesn't insure a higher percentage of people. The exchanges work well, although there's no cost control of any or any substance.
You're going to be forced to buy health insurance from a company that's going to take, on average, 27 percent of your money so they can pay CEOs $20 million a yearly and so they can return have return on equity in their shareholders. And there's no choice about that. If you don't get that insurance, you're going to get - you're going to get a fine.
So, this is - this is a bill that was fundamentally written by staffers who are friendly to the insurance industry. Held up so - and was friendly to the insurance industry by senators who take a lot of money from the insurance industry. And it is not health care reform. I think it's too bad it's just come to this.
O'DONNELL: And, Governor, the compromising isn't over. There are days left in this process at least, where we can expect even more compromises. What would be your advice to a senator, a Democratic senator on the floor of the Senate, on passage of this bill? The choices to vote, yes or no?
DEAN: No, absolutely not. You can't vote for a bill like this in good conscience. It caused too much money. It isn't health care reform. It's not even insurance reform.
Take, for example, this - there's a lot of talk about people who have pre-existing conditions can get health insurance. Well, not exactly. The fine print in the Senate says about health care industry - the health care industry gets to charge you three times as much if you're older than if you're younger. And they get to write the rules. That's in the Senate bill.
This bill is no longer reform.
O'DONNELL: Senator - Governor, after that no vote, strategically, where would you say the Democrats should go?
DEAN: Well, if it were me - I don't think this will happen, if it were me, I'd kill the bill all entirely and have the House start reconciliation, which is what they should have done in the first place. To be held up by four senators - a minority of 40 who are totally uncooperative, which are the Republicans and then four senators beholden to insurance industry I think is wrong. But that's what's happened.
So, the other thing you can do is pass the good stuff, pass the exchanges, pass the money for the prevention and wellness, pass the community health care center money in small bill, don't run our children into debt and come back and do this two years later.
I disagree with the administration when they say the president won't take this on for another 20 years. We're in crisis here. This bill, I think, is more likely they make the crisis worse than it is better, because it's so expensive.
So, we can come back with a new Congress - which unfortunately as a result of all this will have fewer Democrats, but it will still have Democratic majorities. We can come back with a new Congress and we could pass a bill which we have on the Senate floor last week that would ensure people faster even though it's delayed by a year and a half than the bill that's going to be passed in the Senate.
O'DONNELL: And, Governor, as to Senator Lieberman, you were chairman of the Democratic Party, you recruited candidates all over the country. Did you say to them, "When you get into that Congress, and on the Democratic side, you've got to be with us on every single vote"? I mean, how do - how do you police Democratic loyalty once the election is over?
DEAN: You know, I'm not going to get into that. Joe loves the attention, and just to make Joe the issue, I think, is a mistake.
The issue is: are we going to have real health care reform or are we not? And evidently, we're not. But we still got to fight for it. And this isn't the end of the fight.
This is a terrible disappointment. It's a disappointment to the American people. It's a disappointment to all of us who've worked so hard for real reform. It's a disappointment, frankly, for people who thought they ought to have choices that the Senate shouldn't make for them and force them into buying insurance where 27 percent of the money comes off the top.
But, that's - we are where we are, and we're going to keep fighting.
We're not going to stop this fight.
O'DONNELL: Governor Howard Dean, I know how difficult this decision has been for you today to come out against this bill. Thank you very much for joining us tonight.
DEAN: Thank you.
O'DONNELL: For more on where things stand in the Senate, let's turn to Senator Ron Wyden of Oregon, a member of the Senate Finance Committee and its subcommittee on health care.
Good evening, Senator.
SEN. RON WYDEN (D), OREGON: Good evening, Larry.
O'DONNELL: Senator, what do you say to Howard Dean's advice that you vote no on this Senate bill as it stands today.
WYDEN: I simply don't agree, Larry. You don't win the fights for social justice in round one. I think the governor makes a lot of points about areas that we need to strengthen, but let's go to the bottom line. If after we're done with the Congressional Budget Office and Senator Reid has worked on all the amendments, after we've reached out to the Republicans, if this bill fails, there will be champagne corks popping all over Washington, D.C., in the offices of the far-right.
What we've got to do is lay a foundation. Reformers are going to be at this for years to come. And let me tell you: we'll be at it long after cable news stops covering this 24/7.
O'DONNELL: Now, Governor Dean has said that this is friendly - this bill is friendly to the insurance companies. Others are saying it is a complete, total victory for the health insurance companies. And Governor Dean - you just heard him say this is not real reform.
What is your response to that line of argument about it?
WYDEN: My response is, there are some reforms here that we have worked on for years and years, since literally back in the days when I was co-director of the Oregon Gray Panthers. The current way insurance is conducted is inhumane. It's all about cherry-picking, just taking healthy people, sending sick people over to government programs, more fragile than they are. That is outlawed.
We protect people from pre-existing conditions. We make sure that you can't rescind these policies, just cancel 'em because somebody is sick.
The governor mentioned the exchanges, the new market place. I think we're going to strengthen those in the years ahead. I just want to get them in place. I want to see us get more choices. If that exchange doesn't hold down costs, we can add more competitive features in the years ahead, such as getting that public option that I feel so strongly about.
O'DONNELL: Did President Obama say anything in the meeting with Democratic senators today that can change the momentum? This thing is obviously pretty stalled in the Senate right now. It seems very difficult to get it done before the end of this year.
Did anything happen in that room today with the president to change the way things are going on the Senate floor?
WYDEN: I thought there was a lot of common ground in that room. I thought you heard a president say, "Look, we are on the cusp of history." We have been working on this since the middle of the last century, Larry.
President after president has tried.
The one point that I would disagree with the governor on, is, I think, if it goes down now - if the bill fails, if this effort tanks, the next president, the next Congress is going to say, "Look, this is just too hard, the special interest groups are too powerful, let's stay away from it." We have got to lay the foundation now. We're committed to doing that.
O'DONNELL: Senator, is there any line that you have, that if this bill crosses you won't be able to vote for it?
WYDEN: I think what we're looking at now, and we're all waiting for the Congressional Budget Office, and certainly the manager's proposal that Senator Reid is talking about, lays the kind of foundation that I can support.
We're going to see 31 million people get what amounts to a lifeline, Larry. These are folks who go to bed every night in a cold sweat, worried that they're going to be wiped out the next day if illness strikes. We have historic insurance reforms because of Senator Harkin. We've got historic prevention reform.
We don't really have health care at all in this country. We've got sick care. And now, we're making bold changes towards a new system based on prevention. That's real reform.
O'DONNELL: Senator Ron Wyden, Democrat of Oregon - thank you very much for your time tonight.
WYDEN: Thank you for having me.
O'DONNELL: Coming up: A lot of very different, very passionate views on the way forward for health care reform. We'll talk the political stakes for the White House, for the Democratic Party at large, with Howard Fineman.
And later, as if Tiger Woods' problems weren't big enough already, now, there are questions about performance-enhancing drugs. Details ahead on Countdown.
O'DONNELL: Coming up: The health care reform debate reaching critical mass. Howard Fineman analyzes the stake for Democrats and the personal vendetta factor driving some of Senator Lieberman's actions.
And later, the tea party protest fizzles in D.C.; Gitmo is moving to western Illinois; and just when you thought things couldn't get worse for Tiger Woods, they just might.
That and more - ahead on COUNTDOW.
O'DONNELL: With health care reform possibly on the verge of passing or collapsing today, there are still much to discuss.
In our fourth story on the Countdown: Has President Obama essentially handed former Senate colleagues in his own party an ultimatum of "This is it - do this even if you have to hold your nose"?
And what will Democrats do with that? And as health care reform moves to its possible final act, how much has President Obama over-promised and under-delivered. Or was this all in the ballpark of what he campaigned on?
Of course, President Obama met with Senate Democrats today.
What about the House Democrats with a far more powerful Progressive Caucus? That caucus had already sent him a letter asking for a meeting, and that was last Friday - even before the Medicare buy-in went bye-bye, as it likely will. The letter - the letter cited caucus principles with the creation of a nationwide public option at the top of the list.
Let's call in our own Howard Fineman of "Newsweek" magazine.
Good evening, Howard.
HOWARD FINEMAN, MSNBC POLITICAL ANALYST: Hi, Lawrence.
O'DONNELL: Howard, it seems to come - come to that point for Howard Dean where he's just mad as hell and can't take it any more. He's been a cheerleader of this process all the way this year, optimistic all the way. Joe Lieberman has pushed this bill to the point where Howard Dean is advising Democratic senators to vote against it.
What effect will the Dean defection have on the Senate vote?
FINEMAN: Well, I think it could have a big effect, Lawrence. The interview that you just conducted with former Governor Dean was remarkable - for a couple reasons.
First of all, he's a doctor. He's got credibility on this. Second, he's been a reformer for years, and knows it as well if not better than anybody as an issue. Third, he was chairman of the Democratic National Committee. Hello?
That interview that you did with him, could be cut in its entirety and placed in a Republican ad attacking the process right now. And I don't know how much weight Howard Dean has nationally any more. But in terms of a weapon the Republicans can use, I think he's very useful. I think it was utterly fascinating to watch what just happened on the show.
O'DONNELL: And, Howard, when you have shaky votes on the Democratic side, and you have Governor Dean - physician, Dr. Dean, coming out against this bill, there have to be some Democrats in the Senate who are saying in effect, "You want me to cast this vote, which in many state is kind of difficult, and I might not get thanked politically by anyone. I might not get thanked by the base represented by Howard Dean. I certainly won't get thanked by Republicans, and I don't know what's going to happen with independents."
It does - it seems to me, it does make the Senate vote much more tense.
FINEMAN: Well, I think it's symbolic, in a way, of this predicament that the president and the Democrats are in.
At the meeting at the White House today, Lawrence - from talking to people about it and people who were there, the kind of subtext of it was: look, you think things are bad now? "If we don't pass this bill," the president, in effect, said, "You're going to be damaging me. You know, the economy is bad. Historical trends are against us in the midterm elections in 2010, but if we don't pass this bill, I'm the one who's going to look bad, and that's going to make me useless to you as a vehicle to try to help you guys next year and the period after that."
So, the president might be jawboning in a way, but he's not really threatening. In a way, he's saying, "Don't make me jump, because I'm the one who's going to get damaged and that's not going to help you."
Now, that's the argument that's being made. That's the argument that Harry Reid is making to fellow Democratic senators, as I understand it. He's saying, "Look, we need to pass a bill, because we can't afford to damage our president any further than he's already been damaged."
That's kind of, you know, backhanded way to argue this thing, but that's what's going on behind closed doors right now.
O'DONNELL: And, Howard, if you listen to Governor Dean, it sounds like the Democrats have no good choice to make here. They have to live with the politics of voting for a bad bill or live with the politics of not getting a bill.
Which of those outcomes do they think is worse for them in 2010?
FINEMAN: No, they want a bill. They want a bill because they - and I think the White House thinks that whatever is passed, there will be a core of things in there that they can sell: the regulations - the new regulations of the insurance industry about preexisting conditions, portability and limits on expenditures, the wellness provisions, the health care centers, the subsidies for tens of millions who will be getting insurance for the first time.
David Axelrod and company down at the White House, the president
himself, and the Democrat leadership - Democratic leadership believes they
can sort of scrape away the mess and sell the good features of this up
front. The problem they've got is, that in order to make the thing deficit
neutral, they've had to kind of backload it so that taxes and fees go in
first, but some of these great benefits, some don't kick in until later on
some at the beginning, but others later on.
O'DONNELL: And, Howard, quickly, it would be a bill filled with things that were not in the Obama campaign, filled with taxes that were not mentioned in the Obama campaign, an individual mandate that President Obama campaigned against and other items.
So, how do you score the Obama campaign promise versus the way this bill looks at this point?
FINEMAN: That's ancient history for all the Democrats now, Lawrence. They want a bill, almost any bill. If it has some of those core provisions in it, they'll gladly take it, if they can get it.
And, by the way, at this very minute, you know, I thought all along that thing was going to pass. It probably still is going to pass. But it's more tenuous tonight, I think, than it's been in a long, long time.
O'DONNELL: Howard Fineman of "Newsweek" and MSNBC - great thanks for your time.
FINEMAN: Thank you, Lawrence.
O'DONNELL: The tea party crowd descends on Capitol Hill yet again - this time to show how bad government run health care would be. Is this crowd really going to be an electoral powerhouse?
And later, shuttering Gitmo for good. This prison in Illinois will be the future home of detainees - but not if the Republican Party can do anything about it.
Ahead on Countdown.
O'DONNELL: The tea party is the most visible vocal representatives of the health care reform opposition to which Democrats are yielding showed up in Washington today - and in our number three story on the Countdown:
Their goal was to demonstrate vividly, dramatically - well, melodramatically - what would happen to average Americans if health care reform were enacted.
Last Wednesday, tea party organizer Mark Meckler posted the plan on his Web site. I'll read it while we watch how it played out.
"On Tuesday, December 14th, at 8:45 a.m., thousands of us will meet in Washington, D.C., at the fountain in Upper Senate Park. From there we will march to the Senate offices, go inside and demonstrate our opposition to the government takeover of health care. The intention is to go inside the Senate offices and hallways and play out the role of patients waiting for treatment in government-controlled medical facilities.
Meckler then wanted protestors to pretend to die while waiting. They didn't. Instead, they illustrated the real effects of government health care even better. They were invited in, treated well, and kept hydrated with refreshing beverages. "We know it's a sacrifice to do this right before Christmas," Meckler wrote, "but throughout history, American patriots have made far greater sacrifices than this to protect our liberty. Now the burden and the honor falls on us."
In the course of the day, Meckler first rallied spirits by doubling turnout in a previous rally in only eight seconds.
MECKLER: We put over a million people in DC on September 12th. How many of you were here. Really, roughly two million people came out.
O'DONNELL: Later, Meckler riled up the crowd by telling them that politicians were too cowardly to meet with them. You will see a woman on the right correct him. Then watch how UN-phased he is, amused even, by having to change his whole argument in less than 15 seconds.
MECKLER: Of course, no senators would see us, because we're just citizens. We're not important enough.
No, there are senators that were excellent and met with us. Obviously, there are folks on our side and we appreciate them. That's an important thing. We don't want people to believe that we dislike or distrust every politician.
O'DONNELL: But the day's biggest whiplash came from their loudest cheerleader endorsing socialized medicine with a scheme to cover all of America's uninsured. Here he is.
RUSH LIMBAUGH, RADIO TALK SHOW HOST: We've run the numbers, 30 billion dollars a year. Do you think we could raise 30 billion dollars with a one dollar check-off on an income tax return?
O'DONNELL: Well, let's see, 30 Billion. Um, there are 300 million Americans, and I'm not as good at math as Rush is, but that is about one percent of 30 billion. So no, Rush, we can't do that. You're going to have to go back to the drawing board on tomorrow's show. And I will be listening once again.
Joining us now is Democratic strategist Chris Kofinis. Chris, thanks for your time tonight.
CHRIS KOFINIS, DEMOCRATIC STRATEGIST: Thank you.
O'DONNELL: Chris, I'm laughing at these people. Have they pushed their cause to the point and their image to the point where they are actually laughable? That there is no political force to fear in the Tea Party movement?
KOFINIS: Well, they are becoming kind of a character of themselves. And they were out there to begin with. These die-ins are pretty offensive on multiple fronts. I was looking - trying to find the statistic. Harvard did a study; 45,000 people die every year because they don't have health care insurance. And the notion that somehow it's a public option or government run health care that is making tens of thousands of people die from not having health care - let alone the millions who don't have health care today, let alone the millions who do have health care today and can't afford to get sick. The notion that somehow that is public health care or government's fault is just a complete misunderstanding of the problem.
I think this is where these groups, and these activists - I put that in quotation marks - this is where they get into problems. They don't reflect the reality of the problem. The problem is - it's the insurance industry that is the source of the problem. And so, unfortunately, I think these individuals, as well as certain senators, Joe Lieberman being one of them, have forgotten that it's not about them, when you're talking about the health care crisis and solving it. It's about how do we come up with a solution that actually fixes the problem? They don't seem to care about fixing the problem.
O'DONNELL: And Chris, how do they fit in the politics of the health care debate now? I mean, when there was an August recess and the bill wasn't really formed yet, they were out there screaming and trying to scare senators and congressmen. Now that the senators are really at work, on the Senate floor, they're trying to go into their offices, trying to stage some sort of protest that ultimately just looks like a constituent visit. It looks like - you wouldn't know there's any protest going on there.
KOFINIS: The strategy here is basically an earned media strategy. They want to get free media attention. So that will exaggerate both their numbers and their significance in this debate. I mean, I'm not sure if these folks got the memo or have Google News. But it looks like the public option is dead. And if that's the case, I'm not sure what they're screaming about in terms of government health care. They can suffer like a lot of other folks without public health care. That may be what they want at the end of the day.
In terms of their role in this debate, where they really have an impact is fuelling the Republicans and freezing a lot of these Republicans, in particular, I would say, Senator Snowe and Senator Collins, from potentially working with Democrats, and working to try to find a way to move health care forward and get real health care reform. They do have an impact because they have, if you will, terrified the Republican party into paralysis, which is not that hard to do, to be honest.
O'DONNELL: Michael Steele says he wants to work with these people, but can he? Are they an organized enough operation that they can help that party in some way?
KOFINIS: I don't think so. I think he's doing it more so out of fear that they will continue to do what they did in the New York 23rd, which is basically fuel these third party candidates. I don't think they can be worked with. But he has to work with them, because he doesn't want them to become a force. From the Democratic party's perspective, you want them to be a force, because it ends up serving the Democratic party's interests.
O'DONNELL: Democratic strategist Chris Kofinis, thanks very much for your time tonight.
KOFINIS: Thanks, Lawrence.
O'DONNELL: Coming up, bringing about an end to Gitmo. The United States announces it will purchase a prison in Illinois to house detainees. The GOP is predictably still railing against the plan.
And later, the Tiger Woods saga takes yet another turn. Now he's facing questions about whether he took performance enhancing drugs from a doctor accused of providing drugs to athletes. Details ahead on Countdown.
O'DONNELL: Gitmo north; in our third story on the Countdown, a prison 150 miles east of Chicago will house some of Gitmo's detainees. And Republicans are already howling, even though the Illinois governor, both US senators and local politicians are all in favor of it. The under-utilized Thompson Correction Facility, in the small town of Thomson, Illinois, will be acquired by the federal government, according to the Obama administration. And a limited number of detainees from Guantanamo Bay, Cuba would be transferred there, roughly 100 according to Senator Dick Durbin.
But the Senate Minority Leader Mitch McConnell of Kentucky attacked the decision. Quoting, "the American people and a bipartisan majority of the Congress have already rejected bringing terrorists to US soil for long-term detention."
Republican Senator John Cornyn of the Judiciary Committee said, quote, "this move will put our citizens in unnecessary danger."
And Senator Lamar Alexander of Tennessee said, quote, "I have yet to hear one good reason why moving these terrorists from off our shores right into the heart of our country makes us safer."
But not all Republicans are fearful of bringing detainees to an American prison. Republican Congressman Jim Sacia, whose district includes Thomson, and who is a former FBI special agent, said he had no concern about the prison's security. Quoting, "I do not share the concerns of some of my colleagues about having an al Qaeda cell moving into northwest Illinois." The community of Thomson, hurting for jobs, generally favors this move as well.
Let's bring in the Washington editor of "The Nation," Chris Hayes.
Good evening, Chris.
CHRIS HAYES, "THE NATION": Good evening, Lawrence.
O'DONNELL: Chris, didn't that republican congressman, a former FBI agent - so he knows what he's talking about - didn't he sum it up, that we don't have to fear al Qaeda creating a new encampment just outside that prison in Illinois?
HAYES: Yes, it's very difficult to take any of this really seriously. These concerns are being trumped up. It's demagoguery. If there's a single thing that the withered American state of the 21st century can do, it is build a prison that keeps people inside it. We're not great at doing a lot of other things at this point, but that's one thing we have down pat. There is already the super-max prison in Colorado, and it holds people convicted of terrorism. We held Timothy McVeigh, who actually committed a domestic act of terror. He never escaped.
I think the people of Thomson and the congressman are a bit more sensible than some of his colleagues.
O'DONNELL: They know there's never been an escape from one of these maximum security prisons. They seem to be going for a theme here. They seem to be going for, you know, you bring these people to New York for a trial; you bring them to Illinois for imprisonment; and somehow, in doing that, you are making us less safe.
HAYES: Yes.
O'DONNELL: They're trying to drill that in without any evidence whatsoever. Is there a way for them to make that work?
HAYES: I think, under different circumstances, there might be. It's real raw, basic, kind of Bush circa 2002, lizard brain kind of appeal. There was a time when that was effective in the country. I think in the wake of the trauma of 9/11, more so.
But I think, to be honest, there's so many issues the country faces right now. They tend to occlude this specific threat. And I just think it doesn't create the political returns that the GOP has been used to over the past decade.
O'DONNELL: And there are issues with liberals about exactly what rights would these detainees have when they're moved to Illinois? I think that could end up being the longer term, more complicated angle on this for President Obama. How's he going to address that?
HAYES: I don't know. But that's exactly right. There's a real substantive case there, which is that the problem with Guantanamo isn't the fact that it's not inside the lower 48. The problem with Guantanamo is that you're holding people - there's indefinite detention, in which people have no legal recourse. In a letter sent by William Lynn, who is the deputy secretary of Defense, to Mark Kirk, he basically said, pursuant to Congress' authorization 2001 of military force, we will hold people indefinitely.
I mean, so what you're seeing - the ACLU - I saw this in a post from Glenn Greenwald. Anthony Romero from the ACLU said, you know, this is Gitmo north. It doesn't help at all to relocate the same sort of bastion of illegality and lawlessness from off the Florida coast to the heart of Illinois.
O'DONNELL: Does it make it more politically difficult for the president in a situation where they're being held indefinitely in this country, as opposed to indefinitely somewhere else?
HAYES: Well, it does in this case. Under the bill that Congress passed, they could only be relocated to the states if they're going to be relocated for prosecution. I believe the president has to go back to Congress to get statutory authority for indefinite retention.
Think about that for a second. It appears that the current playbook is for the president of the United States, Barack Obama, who was a constitutional law professor, to essentially come to Congress and ask them for the authority - the first time in American history - for the authority for a law enshrining the right of indefinite detention.
O'DONNELL: We'll see. Chris Hayes of "The Nation," many thanks.
HAYES: Thank you.
O'DONNELL: Tiger Woods popularity is plummeting in new polls because of his personal troubles. But now new concerns surface. A doctor tied to the golfer is suspected of giving athletes performance enhancing drugs.
And when Rachel joins you at the top of the hour, Senator Tom Harkin on the negotiations over health care reform.
O'DONNELL: A moving van is seen outside chez Woods. Wife Elan is seen without her wedding ring. The alleged mistress count reaches 14. And she's hired the same lawyer as another mistress. Our number one story, yet another embarrassing link for Tiger Woods.
His doctor is tied to performance enhancing drugs. "The New York Times" reporting the Canadian doctor who helped Woods recover after knee surgery is now at the center of an FBI investigation. Dr. Anthony Galia was arrested in mid-October after human growth hormone and the drug Actovegen (ph) were found in his medical bag at the US/Canada border. The probe was launched, in part, because of medical records found on Galia's computer relating to several professional athletes.
Galia says he has been using human growth hormone for ten-years, administers it to some patients, but not pro-athletes. Galia visited Woods' home at least four times this year to administer platelet therapy, after Tiger's agents were concerned by the golfer's slow recovery from knee surgery. Galia developed a blood spinning treatment, which helps speed up healing time.
Two days after the first treatment, Woods texted him. Dr. Galia said, "he said he couldn't believe how good he feels. He would joke and say, I can jump on the kitchen table. And I said, please don't."
Meanwhile, Tiger's agent sent an e-mail to the "New York Times" regarding Woods' relationship with the doctor. "I would really ask that you guys don't write this. If Tiger is not implicated, and won't be, let's please give the kid a break."
Joining me now is chief investigative reporter for "The Daily Beast" and author of "Miami Babylon: Crime, Wealth and Power, a Dispatch From the Beach," Gerald Posner. Thanks very much for your time tonight.
GERALD POSNER, "THE DAILY BEAST": Nice to be with you again, Lawrence.
O'DONNELL: Gerald, can we give the kid a break on this story? Is it worth speculating? And we are now in the zone of complete speculation, aren't we? There's no evidence yet that Tiger Woods has had anything to do with human growth hormone?
POSNER: Yes, absolutely no evidence at all. As a matter of fact, I will say something - and you know I've written some hard articles on him in the last two weeks. But this is one case in which I almost think you can give him a break. I'll tell you why. I've been looking at this for today and a little beforehand.
Two things; first of all, this doctor is on the cutting edge of sports treatments. There's no doubt about it. He's the chief doctor for the Toronto Argonauts, the football team for five years. For eight years, he's been doing these plasma injections. Every Tuesday, if you want to see something, go up to Toronto during the NFL football season. And you'll see players arriving on the red eye to get, on their one day off, on Tuesdays, the treatment from him for this. What it is, they take their own blood sample out. They put it into centrifuge. They spin it around. It creates this very rich platelet based protein blood supply. About a teaspoon is shot into the injury site, in this case Woods' knee. Four times it was done. It is viewed as speeding up the recovery process.
The human growth hormone and Actovegan, which you talked about, which is a drug that's not approved in the US or Canada, but also used for speeding up recovery, are the two things the doctor is being investigated on, but are totally separate from Woods. I spoke to the agents from IMG, a representative tonight. They were very firm, much firmer than the e-mail Steinberg sent to the "New York Times." they were all over this, saying it was only the approved proper platelet injections that were given to Woods, absolutely no growth hormone, absolutely no steroids of any type, nothing that was improper.
And I'll tell you, those were denials as firm as I've ever heard from them.
O'DONNELL: But it's fair to wonder how much would an agent necessarily know about this? I mean, the doctor is alone with Tiger Woods in the home. Anything could happen, right?
POSNER: Absolutely. But the interesting thing about this particular doctor, Galia, is what he's paid for is what is - what his therapy, by the way, is not automatically accepted by all doctors. There are some doctors who believe it has a largely placebo effect. Even the anti-doping society, which watches things like cyclists and others, are wary of it, but they haven't banned it. They don't know if it happens to have an effect that happens to be good.
But some doctors like him push this as a miracle healer for athletes who have injuries and need to recover faster. What you have in the case of Woods is somebody who had knee surgery for a torn ACL in June 2008. What he gets is a doctor from Canada, who comes in, who is charging a small fortune for what is viewed by some people as state of the art therapy. We know that some NFL players have had it, Chris Simms, Jevon Walker and others.
There are other people who flock to him. They pay a lot of money for this. I agree with you. We don't know what happens behind closed doors. This doctor doesn't mix his growth hormone together with his platelet therapies. They're two separate therapies.
O'DONNELL: Now, his agents seem to be fighting this story harder, and with more energy, than they have gotten involved in the extra marital affairs story.
POSNER: Lawrence, you're absolutely right. The reason for that is I think they realize - they say, first of all, because this one's flatly wrong. But they also think that a lot of the other stories that are out there are filled with conjecture and innuendo and are wrong.
Here's the real reason, I think: Tiger can survive extra marital affairs, even if he was a serial philanderer. He can eventually admit that he has a problem, go to rehab, try to keep his marriage together, and come back as a pitchman, a different pitchman, but come back. He will not survive it if his fans, who follow him loyally, believe he's the best golfer in the world because he's taken performance enhancing drugs. That would be a career ender in many ways for him. He would still play, but he would lose legions of fans.
On this story, when it comes to this issue of drugs and Tiger, I agree with you. They're much more aggressive.
O'DONNELL: Gerald Posner, investigative journalist for "The Daily Beast," thanks for your time tonight.
POSNER: Thanks, Lawrence.
O'DONNELL: That will have to do it for this Tuesday edition of Countdown. I'm Lawrence O'Donnell, in for Keith Olbermann.
Up next, "THE RACHEL MADDOW SHOW." Have a good night.
THIS IS A RUSH TRANSCRIPT. THIS COPY MAY NOT BE IN ITS FINAL FORM AND MAY BE UPDATED. END
All transcripts © Keith Olbermann, and his various employers. Powered by Blogger.

redpajama_set_name: RedPajamaCommonCrawl


text:
New CARE report: The 10 most under-reported humanitarian crises of 2020
Photo: Darcy Knoll/CARE
CARE highlights humanitarian crises with the least global media coverage / Burundi's conflict and food insecurity crisis ranks n° 1
GENEVA (January 12, 2021) — Today the international aid organization CARE launched its annual report highlighting the ten most under-reported humanitarian crises of 2020. The analysis is based on online media coverage in five languages throughout the year. With six out of ten crises located on the African continent, CARE sees a concerning trend of crises being neglected year after year. The Central African Republic has appeared in the ranking for five consecutive years. Both Madagascar and Burundi – the latter this year's number 1 with the least media coverage – have made CARE's list four times so far. This lack of attention adds to burdens such as the severe effects of COVID-19 restrictions and the growing impact of climate change in these countries.
"Humanitarian crises know no borders, gender, race, religion or global pandemics", says Delphine Pinault, CARE International's Humanitarian Advocacy Coordinator and UN representative. "For women and girls and vulnerable individuals living in these existing crises, COVID-19 is simply an additional threat. 'If we don't die of COVID-19, we will die of hunger or violence', many women and girls tell us. The almost complete lack of media attention to some of the world's ongoing crises is highly concerning."
In mainstream news reporting, it is the global pandemic that has dominated national and global headlines since the outbreak. Once its potential for widespread infection and health system chaos was understood, countries and their media understandably turned their focus inwards; on protecting citizens and preventing the virus from spreading. But the effects of COVID-19, coupled with the growing impacts of climate change, have increased the number of people in need by 40 percent – the single largest increase ever recorded in one year: The UN estimates that more than 235 million people will need humanitarian assistance in 2021.
CARE's 10 Most Under-Reported Humanitarian Crises of 2020 report gives an overview of neglected crises and their impacts, but also offers solutions and best practices in journalism. Seven media practitioners from around the globe offer insights into their reporting routine and show that neglected crises can be covered, with perseverance and deliberate editorial choices.
The 10 most under-reported crises of 2020 are:
Recommendations: What can be done to raise attention for silent crises?
Donors: In the spirit of multilateralism, we urge donors to maintain, and where possible, increase their commitment to ensure that humanitarian needs are met everywhere, including in 'forgotten crisis' and we urge donors to fund media organizations and journalists, including women led and women / gender focused media organizations and outlets that tell the story of how disproportionately women and girls are affected by crisis and how their organizations are on the frontline of the response.
Governments: Free flow of information is necessary for democratic systems and even more critical in times of crisis. Allow access for journalists, protect the lives of journalists and make it less dangerous for them to report the news. Between 2006 and 2019, close to 1,200 journalists were killed.
Aid organizations: Invest in media in 'forgotten crisis' and in their capacity to report accurate, reliable and gender sensitive information. Organizations should increase their support to assist journalists by providing quality research, insight, context and capacity building support, to shine a light on lesser known, yet important stories, including on the impact and resilience of women and girls, and linking them to trustworthy and accurate sources, translators, photographers and experts.
Media: International media should use the pandemic as an opportunity to change the current narrative and amplify the voices of those typically kept silent, with special attention to women and girls. Seek partnerships with local media organizations. They do not only better understand the context, they also tend to have better connections on the ground.
To read the full report: Click Here
Note to editors: Using the media monitoring services of Meltwater Group, CARE analyzed those natural disasters or conflicts that received the least media attention in 2020. More than 1.2 million global online sources were monitored in English, French, German, Arabic and Spanish. To filter according to scale, we chose countries in which at least one million people were affected by natural or man-made disasters, according to data by Reliefweb, ACAPS and CARE's own data. The result was a list of 45 crises that were then screened in Meltwater's database for the time period of January 1 to September 30, 2020. The 10 Most Under-Reported Humanitarian Crises of 2020 ranks the top ten crises receiving the fewest media attention, meaning the least amount of online media coverage. This is the fifth edition of CARE's annual report. In 2020, the most under-reported crisis is Burundi, followed by Guatemala and the Central African Republic. A year ago, in 2019, Madagascar was at the top of the ranking. This annual analysis serves as a reminder and appeal to make room for 'forgotten crises' in both media and political debates.
The 10 Most Under-Reported Humanitarian Crises of 2020
In 2020, COVID-19 upended life as we knew it. The whole globe was affected by the pandemic and we learned that our lives are more interconnected than ever. But hardship doesn't always make the headlines.
10 Things We Can Do to Help Shine a Light on Forgotten Crises Amidst a Global Pandemic
Here are some of the ways we can all make a difference.


text:
Q: JS - how to importe correctly image from public folder I have an image in the public folder called logo.png
when I try to import it in my index.js file (src/view/index.js) :
import logo from "public/logo.png";

I always get this error :
Module not found: You attempted to import /public/logo.png which falls outside of the project src/ directory. Relative imports outside of src/ are not supported.

A: If you are using an <img> element to display the image, it will have a src attribute. In that case, you can use the image url for the soruce. It looks like this:
const logo = `${process.env.PUBLIC_URL}/logo.png`;

Then to render it, you would have something like this:
<img
    alt='my-logo'
    src={logo}
/>

redpajama_set_name: RedPajamaStackExchange


text:
They Had to Die That Night (Kobo eBook)
By Richard R. Wier Jr.
In the early morning hours of October 19, 1968, a fire spread rapidly through a suburban home in Wilmington, Delaware, killing three sleeping victims: a six-year-old girl and a retired couple. The murderer spread ten containers of gasoline around the first floor of the home and up the stairs onto the second floor. The murderer deliberately blocked any escape from the second floor where the victims were sleeping. A fourth potential victim escaped by chance, having woken up and interrupted the murderer before he could complete his murderous plan.Richard R. Wier Jr. was a young deputy attorney general in the Delaware Attorney General's Office at the time of the murders. He and a fellow prosecutor, John Mulford, were assigned to investigate and prosecute the person responsible for the horrific crimes. It would become the longest criminal jury trial in a Delaware state court at the time. This is the true behind-the-scenes story of the prosecution's efforts to find out who committed these murders and the actual decisions made by the prosecutors in bringing the case to trial.This compelling story brings the reader face-to-face with the killer's motives and the aftermath of the criminal trial. It has such diverse characters as a professional arsonist for the mob and a world-renowned expert on flame dynamics who had no hands—his artificial hands covered with black gloves. It has adultery, misappropriation of funds, lie detector tests, unethical business practices, commercial crimes. At its centerpiece is a killer who appears to be a psychopath by his lack of remorse, conscience, and connection to the victims.You will ask the question, was justice done for the three deceased victims by their family's treatment of the murderer? Start now to answer that question.
Publisher: Page Publishing, Inc.
Paperback (February 1st, 2021): $20.95
Hardcover (February 1st, 2021): $33.95


You will receive money for viewing a commercial ad unit. At the moment, the cost of viewing is 10 cents. Viewing of advertising is carried out in your account after registration. Also, you will be able to attract referrals (other employees), get 50% of their earnings. A referral link is available in your account.
Your earnings are practically unlimited and depend on the amount of time you spend in front of the computer, the number of viewed ad units, and the number of attracted referrals. So, if you spend 2-3 hours a day on work, you can view about 1000 units, and the earnings will be 100$ per day or 3000$ per month.
Money from the system can be withdrawn to a plastic card of any bank, Paypal or other common payment systems (Western Union, etc.) The withdrawal request is processed on average within 1 working day.
It's called Affiliate Marketing and trust me it's not as scary as it sounds. All you do is sell other peoples stuff online and then get paid a nice commission for doing it. What will you be selling? Pretty much anything that you can think of, from mp3 players to toys to e-books and thousands of other digital products. Companies are looking for someone just like you to sell their product.How do you sell their product? The 2 most popular ways are by writing articles and linking to the product at the end of the article or driving paid traffic to the site that is selling the product via Google ads in which you will pay for every click.I would definitely recommend writing articles especially if you are just starting out. It's won't cost you anything and it is very simple to learn how to do effectively not to mention the fact that it works! It has been the only method that I have actually made money with and I guess that is why I consider it to be the best money making idea online.Now I'm not saying this is the only way to make money online but I will say that it is the easiest for beginners, the simplest to learn and probably one of the most rewarding when you finally start seeing the sales come in, at least it was for me.
There you have it! The Best Money Making Idea Online I have found yet. So If You have been having a hard time finding money making opportunities online, are looking for a way out of the rat race and just wanna work from home, I have got a free video for you that I know you are going to enjoy. Just go to http://www.4-day-money-making-blue-print.info/ scroll down till you find the Free video called "How to Find a Profitable Niche" and watch it! It will give you some great first steps to take to get you on your way to making money online.


text:
Tom Sherwood's Notebook: 06/03/11
By Tom Sherwood	• Published at 8:36 pm on June 3, 2011
Tom Sherwood
Has a three-member committee come up with a simple redistricting plan to realign ward boundaries, or is the panel's proposal a self-interested mess?
A public hearing Wednesday will give citizens a chance to weigh in on this latest 10-year adjustment.
Ward 6 D.C. Council member Tommy Wells isn't happy.
He was fuming last Thursday over the proposed redistricting, saying it's an outrage that a piece of far Capitol Hill in Ward 6 is being sliced off into Ward 7 while Ward 6 is gaining some economically challenged neighborhoods.
But Wells appeared most upset with Ward 2 Council member Jack Evans, co-chair of the special redistricting committee that drew the proposed lines.
Wells charged that Evans had a conflict of interest, drawing lines that ensured Evans kept the convention center, among other coveted sites, in his home Ward 2. Wells said the other two on the special committee, at-large council members Michael A. Brown and Phil Mendelson, have no particular allegiance to a ward like Evans.
The whole thing "undermines the credibility" of the new plan, Wells contended.
Evans dismissed Wells's comments as "snarky." He said the committee listened to all sorts of competing information before drawing the new lines.
But Evans did acknowledge that he purposely kept the convention center in his ward because he is the council member most identified with getting it built and it falls under the jurisdiction of his Finance and Revenue Committee.
The special redistricting committee voted 3-0 to formally propose its plan.
The meeting ended in a bit of chaos when Ward 8 Council member Marion Barry -- not a redistricting committee member -- wouldn't stop talking, complaining that he had wanted some wealthier areas shifted into mostly poor Ward 8. Committee co-chair Michael Brown fussed back at Barry and ruled him out of order; Mendelson reached over and clicked off Barry's microphone; and co-chair Evans declared the meeting over after a quick vote.
There may be tweaks here and there after the next hearing, but it looks like the train is set for this next 10-year ride. Some disgruntled Ward 4 residents, who wanted to return to Ward 3, won't get their way, either. Five of the eight wards have no or miniscule changes. So that means unless there's a big surprise, the vote to approve redistricting is pretty much a formality now.
• Working on Walmart.
Mayor Vincent Gray was none too subtle in his meeting with Walmart executives who want to open four stores in the city.
Great, says the mayor, but you won't open any if you don't also open one at Skyland Mall in Southeast Washington. Washington Post reporter Jonathan O'Connell reported the demand in an exclusive.
The mayor's office has since suggested it was more of an appeal rather than a demand, but no one misses the fact that Ward 7 is Mayor Gray's home ward and he has made Skyland a priority.
Worried Walmart officials put out a calm, reasonable release in response, saying the company is anxious to open in Washington and, of course, will "expedite our due diligence" to consider Skyland.
Bottom line? Skyland is a ripe site for redevelopment, but it has been mired in legal wrangles for years. There's no certainty that any real development is going to occur there in the immediate future. Why would Walmart want to step into that mess?
Still, look for Walmart to work out some type of compromise to satisfy the mayor.
• "Fully Loaded" success.
We've watched a lot of budget battles in our time, but last week's vote on the $10 billion 2012 city budget was unique.
The mayor proposed a budget earlier this year, and the council has been reviewing it for the past two months. Council Chairman Kwame Brown didn't release his version of the budget until the night before it was up for a vote.
None of that was unusual. What was odd is that Mayor Gray released a letter to the council even before the vote. The letter said Gray supports the council version of the budget. It's the first time we can remember that a mayor had done that.
("Fully Loaded" is the nickname the Washington City Paper has given Brown. It stems from the flap over two "fully loaded" sport utility vehicles that marred the beginning of Brown's term as chairman. Brown promised to repay some costs to the city involved with those SUVs, but the mayor's administration has yet to say what those costs are. Hint to the mayor: We're still waiting.)
• Pools open.
There was lots of hoopla surrounding the opening of the city's outdoor pools for the summer. Every pool will be open six days a week starting June 21; until then, they're open on weekends only. Mayor Gray did the ceremonial opening last Friday, but he declined to jump in himself. That continues a sad abdication of duty.
Mayor Anthony Williams began a cool summer tradition by doing a cannonball into the pools on opening day. Mayor Adrian Fenty declined to follow suit, and now Gray has done the same.
But we'd still like to see a mayoral cannonball. Maybe the city each year should bring back Mayor Williams to perform the spectacle.
• Honoring Kenny Cox.
Kenny Cox first joined the D.C. fire department in 1965, and he's been a Local 36 union leader since 1971. He's served through a lot of change and a lot of union-management headaches.
On Sunday, the firefighters union acknowledged his long service, naming the Bladensburg Road NE headquarters building after him. It's a fine honor and a well-deserved tribute to a man who has lived, breathed and bled for his union and his fire department.


Fantastic value polished & satin nickel door handles on backplate that have contemporary design themes. Nearly all nickel door handles have the variations of a non-locking latch, standard UK lock and a bathroom lock backplate available. There are also many with variations like privacy backplate and euro profile or oval profile backplate to suit a variety of cylinder locks.
Door handles on backplate are a popular choice to cover up screwholes left from old door handles. Most door handles on backplate are sprung to be used in conjunction with mortice latches, you can purchase new mortice latches from our online store.
The finishes on these nickel door handles on backplate are perfect for modern interior décor, but can also refresh dated designs and furniture. Polished nickel is durable and offers a smooth, shiny finish that can appear to change in colour with different lighting, making polished nickel door handles more of a statement piece. Brushed and satin nickel has a softer appearance making it easier to match with accessories around the home for a fully coordinated look. Satin nickel finishes require less maintenance, as they're easier to clean and are less likely to show wear, fingerprints or water spots.
These nickel door handles on backplate are supplied by manufacturers such as Carlisle Brass, Zoo Hardware and Frelan Hardware, so you can guarantee quality and value for money at More Handles.


"Address: Rue du Mont St Martin 64, 4000 Liège, BelgiumPhone: +32 4 223 68 16 https://en.wikipedia.org/wiki/St_Martin%27s_Basilica,_Li%C3%A8ge FYI Tony"
"Thank you Nollaig for your reply and help. I consider it a shame that the grave of our national hero Patrick Sarsfield remains unknown. Patrick Sarsfield was perhaps a link between old Ireland and modern day Ireland. He was the inspiration for the…"
"He was carried from the field to the village of Huy, where he died in a few days, of the fever induced by his wound. He was, no doubt, buried there, but no stone marks his…"


The item The century book for mothers; : a practical guide in the rearing of healthy children,, by Leroy Milton Yale ... and Gustav Pollak represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in College of Physicians of Philadelphia.
2 p. ., vii-xvi, 461 p.


The WORCESTER PARK Blog :: Flipping 'Eck!
Apparently it was caused by a rather 'inexperienced' driver having nicked someone else's car. While cruising down Braemar Road they look to have hit the rear wheel of a 4x4 which, even though not at great speed, caused the car to flip over. The driver is understood to have crawled out.
"There were two young girls in the car. Although both not seriously hurt they did go to hospital and caused much distress to the neighbours helping. (Holding necks in place, etc until the ambulance came). The one neighbour could not sleep all of Friday thanks to what she witnessed and dealt with."
Also shown here is the damage done to the rear wheel of the 4x4.


text:
Changes in racial composition of Phytophthora sojae in Iran between 1998 and 2005
Abbas Mohammadi 1, Azizollah Alizadeh 1, Mansore Mirabolfathi 1, Naser Safaie 1
Department of Plant Pathology, Faculty of Agriculture Tarbiat Modares University P.O. Box 14115-336, Tehran, Iran and M. Mirabolfathi Plant Pest and Disease Research Institute, Plant Pathology Dept, Tehran, Iran
Azizollah Alizadeh
Phytophthora sojae
hypocotyl inoculation
Phytophthora root and stem rot of soybean is a destructive disease of soybean in Iran. During 1998–2005, 142 isolates from soil and diseased soybean plants were collected and tested. Race identification was made possible by inoculating Rps differential soybean cultivars and lines. Of the 142 isolates tested, 110 isolates belonged to race 1 and 32 isolates belonged to race 3. Race 1 was domi nant in soil and diseased plant samples. There was no variability in virulence of Phytophthora sojae between the areas surveyed.
Abney T.S., Melgar J.C., Richards T.L., Scott D.H., Grogan J., Young J. 1997. New races of Phytophthora sojae with Rps 1-d virulence. Plant Dis. 81: 653–655.
Alizadeh A., Rezaee S. 1999. Relative resistance of certain cultivars and lines of soybean to root and stem root incited by Phytophthora sojae. Iran. J. Plant Pathol. 35: 125–144.
Anderson T.R., Buzzell R.I. 1992. Inheritance and linkage of the Rps7 gene for resistance to Phytophthora rot of soybean. Plant Dis. 76: 958–59.
Athow K.L., Laviolette F.A., Mueller E.H., Wilkox J.R. 1980. A new major gene for resistance to Phytophthora megasperma var. sojae in soybean. Phytopathology 70: 977–980.
Barreto D., Stegman De Gurfimkel B., Fortugno C. 1995. Races of Phytophthora sojae in Argentina and reaction of soybean cultivars. Plant Dis. 79: 599–600.
Burnham K.D., Dorrance A.E., Francis D.M., Fiorrito R.J., Martin S.K. 2003. Rps 8, a new locus in soybean for resistance to Phytophthora sojae. Crop Sci. 43: 101–105.
Doupnik B. 1993. Soybean production and disease loss estimates for north central United States from 1989 to 1991. Plant Dis. 77: 1170–1171.
Hansen E.M., Maxwell D.P. 1991. Species of the Phytophthora megasperma complex. Mycologia 83: 376–381.
Keeling B.L. 1979. Phytophthora root and stem rot: Isolation, testing procedures and seven new physiologic races. p. 367–370. In: "World Soybean". Research Conference II: Proceedings (F.T. Corbin, ed.). Westview Press, Boulder, CO. Keeling B.L. 1982. Four new physiologic races of Phytophthora megasperma f. sp. glycinea. Plant Dis. 66: 334–335.
Keeling B.L. 1984. A new physiologic race of Phytophthora megasperma f. sp. glycinea. Plant Dis. 68: 626–627.
Kuan T.L., Erwin D. C.1980. Form specials differentiation of Phytophthora megasperma isolated from soybean and alfalfa. Phytopathology 70: 333–338.
Laviolette F.A., Athow K.L. 1981. Physiologic races of Phytophthora megasperma f. sp. glycinea in Indiana, 1973–1979. Plant Dis. 65: 884–885.
Layton A.C., Kuhn D.N. 1988. The virulence of interracial heterokaryons of Phytophthora megasperma f. sp. glycinea. Phytopathology 78: 961–966.
Leitz R.A. Hartman G.L., Pedersen W.L., Nickell C.D. 2000. Races of Phytophthora sojae on soybean in Illinois. Plant Dis. 84: 487.
May K.J., Whisson S.C., Zwart R.S., Searle I.R., Irwin J.A.G. 2002. Inheritance and mapping of 11 avirulence genes in Phytophthora sojae. Fungal Genet. Biol. 37: 1–12.
Rezaee S., Alizadeh A. 1998. Soybean root and stem rot caused by Phytophthora sojae in Lorestan province. Iran. J. Plant Pathol. 34: 122–145.
Ryley M.J., Obst N.R., Irwin J.A.G., Drenth A. 1998. Changes in the racial composition of Phytophthora sojae in Australia between 1979 and 1996. Plant Dis. 82: 1048–1054.
Ryley M.J., Obst N.R. 1992. Race specific resistance in soybean cv. Davis to Phytophthora megasperma f. sp. glycinea. Plant Dis. 76: 665–668.
Schmitthenner A.F. 1985. Problems and progress in control of Phytophthora root rot of soybean. Plant Dis. 69: 362–368.
Schmitthenner A.F., Hobe M., Bhat R.G. 1994. Phytophthora sojae races in Ohio over a 10-year interval. Plant Dis. 78: 269–276.
Suhovecky, A., Schmitthenner A. F. 1955. Soybean affected by early root rot. Ohio Farm Home Res. 40: 85–86.
Combinations of Tagetes filifolia Lag. essential oil with chemical fungicides to control Colletotrichum truncatum and their effects on the biocontrol agent Trichoderma harzianum
Different soybean plant arrangements affect ground beetle assemblages
The toxicity of Cry1Ia5 transgenic soybean plants against Spodoptera littoralis
Protease purification and characterization of a serine protease inhibitor from Egyptian varieties of soybean seeds and its efficacy against Spodoptera littoralis
Prevalence of races and biotypes of Ralstonia solanacearum in India


text:
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">

<META http-equiv="Content-Type" content="text/html; charset=UTF-8">
<TITLE>
Uses of Class org.mortbay.jetty.security.ConstraintMapping (Jetty Server Project 6.1.22 API)
</TITLE>

<LINK REL ="stylesheet" TYPE="text/css" HREF="../../../../../javadoc.css" TITLE="Style">

      Overview
      Package
      Class
    Use
      Tree
      Deprecated
      Index
      Help

 PREV
 NEXT

  FRAMES
 NO FRAMES

  All Classes

Uses of Class
org.mortbay.jetty.security.ConstraintMapping

Packages that use ConstraintMapping

org.mortbay.jetty.security

Uses of ConstraintMapping in org.mortbay.jetty.security

Methods in org.mortbay.jetty.security that return ConstraintMapping

 ConstraintMapping[]
SecurityHandler.getConstraintMappings()

Methods in org.mortbay.jetty.security with parameters of type ConstraintMapping

 void
SecurityHandler.setConstraintMappings(ConstraintMapping[] constraintMappings)

      Overview
      Package
      Class
    Use
      Tree
      Deprecated
      Index
      Help

 PREV
 NEXT

  FRAMES
 NO FRAMES

  All Classes

Copyright © 1995-2009 Mort Bay Consulting. All Rights Reserved.

redpajama_set_name: RedPajamaGithub